磷酸化蛋白激酶AKT1抗体

磷酸化蛋白激酶AKT1抗体

〖别名〗p-AKT1 (phospho S473);phospho-AKT1(Ser473); AKT1 (phospho S473); AKT 1; AKT; AKT1; AKT1_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB-ALPHA; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alpha serine/threonine protein kinase; RAC; RAC PK Alpha; Rac protein kinase alpha; RAC Serine/Threonine Protein Kinase; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; v akt murine thymoma viral oncogene homolog 1; vAKT Murine Thymoma Viral Oncogene Homolog 1.  

〖浓度〗1mg/1ml 

〖规格〗0.1ml/100μg   

〖抗体来源〗磷酸化蛋白激酶AKT1抗体Rabbit  

〖克隆类型〗polyclonal 

〖交叉反应〗Human, Mouse, Rat, Chicken, Dog  

〖产品类型〗一抗  磷酸化抗体  

〖研究领域〗肿瘤 细胞生物 信号转导 激酶和磷酸酶 新陈代谢 表观遗传学  

〖蛋白分子量〗predicted molecular weight: 60kDa 

〖性状〗Lyophilized or Liquid 

〖免疫原〗KLH conjugated synthesised phosphopeptide derived from human AKT1 around the phosphorylation site of Ser473 

〖亚型〗IgG 

〖纯化方法〗affinity purified by Protein A 

〖储存液〗Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4 

〖产品应用〗WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500 

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

〖保存条件〗Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

〖产品介绍〗Plays a role as a key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). General protein kinase capable of phosphorylating several known proteins. Phosphorylates TBC1D4. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). Plays a role in glucose transport by mediating insulin-induced translocation of the GLUT4 glucose transporter to the cell surface. Mediates the antiapoptotic effects of IGF-I. Mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. Promotes glycogen synthesis by mediating the insulin-induced activation of glycogen synthase. The activated form can suppress FoxO gene transcription and promote cell cycle progression. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly.

Subcellular Location : Cytoplasm. Nucleus. Cell membrane. Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2 results in its localization to the cell membrane where it is targeted for further phosphorylations on Thr-308 and Ser-473 leading to its activation and the activated form translocates to the nucleus.

Tissue Specificity : Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages.

Post-translational modifications : Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Activated TNK2 phosphorylates it on Tyr-176 resulting in its binding to the anionic plasma membrane phospholipid PA. This phosphorylated form localizes to the cell membrane, where it is targeted by PDPK1 and PDPK2 for further phosphorylations on Thr-308 and Ser-473 leading to its activation. Ser-473 phosphorylation by mTORC2 favors Thr-308 phosphorylation by PDPK1. Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is enhanced in focal cortical dysplasias with Taylor-type balloon cells.

Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced 'Lys-63'-linked AKT1 ubiquitination is critical for phosphorylation and activation. When ubiquitinated, it translocates to the plasma membrane, where it becomes phosphorylated. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome.

DISEASE : Defects in AKT1 are a cause of susceptibility to breast cancer (BC) [MIM:114480]. A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

Defects in AKT1 are associated with colorectal cancer (CRC) [MIM:114500]. Defects in AKT1 are associated with susceptibility to ovarian cancer [MIM:604370]; also called susceptibility to familial breast-ovarian cancer type 1 (BROVCA1).

Similarity : Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. 

RAC subfamily.

Contains 1 AGC-kinase C-terminal domain.

Contains 1 PH domain.

Contains 1 protein kinase domain.

本公司产品现货供应,货期短，质量可靠。仅用于科研实验不应用于临床。我们用专业的态度，一流的服务，全程实验指导，让你的数据不在成为实验奇谈。选择优质的磷酸化蛋白激酶AKT1抗体，你的小伙伴都会惊呆的。本公司专业供应各种进口、国产一抗及二抗。代理品牌有R&D、Santa Cruz、Bipec、Millipore等国际知名品牌，品种多达7000多种。让你的科研之路不再布满荆棘。

我们还可以为客户提供产品说明书。磷酸化蛋白激酶AKT1抗体拥有高纯度、高效价、高特异性的特点，可以应用于多种实验。免费送货上门，为您大大节省了时间和金钱。

Ab-(001)-01069 神经丝蛋白抗体（人） ，英文名： Anti-AD7C-NTP/NTP/AF human ，规格： 0.1ml

Ab-(001)-01070 整合素样金属蛋白酶与凝血酶1型(抗体) ，英文名： Anti-ADAM-TS1/METH1 ，规格： 0.1ml

Ab-(001)-01071 整合素样金属蛋白酶与凝血酶1型-7(抗体) ，英文名： Anti-ADAM-TS7 ，规格： 0.1ml

Ab-(001)-01072 整合素样金属蛋白酶与凝血酶1型-12抗体 ，英文名： Anti-ADAM-TS12 ，规格： 0.1ml

Ab-(001)-01073 禽脑脊髓炎病毒抗体 ，英文名： Anti-AEV ，规格： 0.1ml

Ab-(001)-01074 抗利尿激素/血管升压素抗体 ，英文名： Anti-ADH/AVP ，规格： 0.1ml

Ab-(001)-01075 肾上腺髓质素抗体(N端20肽) ，英文名： Anti-ADM ProAM-N20 ，规格： 0.1ml

Ab-(001)-01076 腺苷受体A3抗体 ，英文名： Anti-ADORA3/A3AR ，规格： 0.1ml

Ab-(001)-01077 芳香烃受体抗体 ，英文名： Anti-AHR ，规格： 0.1ml

Ab-(001)-01078 α-L-阿拉伯呋喃糖苷酶抗体 ，英文名： Anti-α-AF/α-Afa ，规格： 0.1ml

Ab-(001)-01079 血管组织血管紧张素Ⅱ1型受体抗体 ，英文名： Anti-Agtr1/AT1a ，规格： 0.1ml

Ab-(001)-01080 醛缩酶A抗体 ，英文名： Anti-ALDA ，规格： 0.1ml

Ab-(001)-01081 肝再生增强因子抗体 ，英文名： Anti-ALR ，规格： 0.1ml

Ab-(001)-01082 抗碱性磷酸酶抗体 ，英文名： Anti-AP/ALP ，规格： 0.1ml

Ab-(001)-01083 α－甲基酰基辅酶A消旋酶抗体 ，英文名： Anti-AMACR/P504S ，规格： 0.1ml

Ab-(001)-01084 神经元突触前膜蛋白抗体 ，英文名： Anti-Amph ，规格： 0.1ml

Ab-(001)-01085 β淀粉样肽1-42 (C端抗体) ，英文名： Anti-β-Amyloid 1-42 ，规格： 0.1ml

Ab-(001)-01086 β淀粉样肽（1-16）抗体 ，英文名： Anti-β-Amyloid ，规格： 0.1ml

Ab-(001)-01087 β淀粉样肽β-Amyloid 1-40/Aβ1-40 C端抗体 ，英文名： Anti-β-Amyloid 1-40/Aβ1-40 ，规格： 0.1ml

Ab-(001)-01088 血管生成素-1抗体 ，英文名： Anti-ANG-1 ，规格： 0.1ml

Ab-(001)-01089 血管生成素-2抗体 ，英文名： Anti-ANG-2 hu, mo, rat, pig, dog, chi ，规格： 0.1ml

Ab-(001)-01090 锚定蛋白G抗体 ，英文名： Anti-Ankyrin G/ANK-3/ankyrin 3 ，规格： 0.1ml

Ab-(001)-01091 心钠肽（心钠素）抗体 ，英文名： Anti-ANP ，规格： 0.1ml

Ab-(001)-01092 血管紧张素Ⅱ-2型受体抗体 ，英文名： Anti-AT2R ，规格： 0.1ml

Ab-(001)-01093 膜粘连蛋白A1抗体 ，英文名： Anti-ANXA1/P35 ，规格： 0.1ml

Ab-(001)-01094 膜粘连蛋白 I抗体 ，英文名： Anti-Annexin I ，规格： 0.1ml

Ab-(001)-01095 膜粘连蛋白 Ⅱ抗体 ，英文名： Anti-Annexin Ⅱ ，规格： 0.1ml

Ab-(001)-01096 膜粘连蛋白 Ⅲ抗体 ，英文名： Anti-Annexin Ⅲ ，规格： 0.1ml

Ab-(001)-01097 膜粘连蛋白 Ⅳ抗体 ，英文名： Anti-Annexin Ⅳ ，规格： 0.1ml

Ab-(001)-01098 膜粘连蛋白 V抗体 ，英文名： Anti-Annexin V ，规格： 0.1ml

Ab-(001)-01099 膜粘连蛋白 VI抗体 ，英文名： Anti-Annexin VI ，规格： 0.1ml

Ab-(001)-01100 重组膜粘连蛋白-5(人)抗体 ，英文名： Anti-Annexin V ，规格： 0.1ml

Ab-(001)-01101 炭疽菌抗体 ，英文名： Anti-Anthrax ，规格： 0.1ml

Ab-(001)-01102 衔接蛋白α抗体 ，英文名： Anti-alpha Adaptin/AP1 ，规格： 0.1ml

Ab-(001)-01103 衔接蛋白β抗体 ，英文名： Anti-beta Adaptin/AP2 ，规格： 0.1ml

Ab-(001)-01104 衔接蛋白γ抗体 ，英文名： Anti-γ-Adaptin ，规格： 0.1ml

Ab-(001)-01105 凋亡蛋白活性因子-1抗体（C端） ，英文名： Anti-Apaf-1 ，规格： 0.1ml

Ab-(001)-01106 活化蛋白C抗体 ，英文名： Anti-APC ，规格： 0.1ml

Ab-(001)-01107 脂肪炎症因子Apelin抗体 ，英文名： Anti-Apelin ，规格： 0.1ml

Ab-(001)-01108 Apelin receptor抗体 ，英文名： Anti-Apelin receptor/APJ receptor ，规格： 0.1ml

Ab-(001)-01109 氧化还原因子1抗体 ，英文名： Anti-APEX1/Ref-1 ，规格： 0.1ml

Ab-(001)-01110 凝血酶Ⅲ抗体 ，英文名： Anti-ATH Ⅲ ，规格： 0.1ml

Ab-(001)-01111 APG4B细胞自噬相关抗体 ，英文名： Anti-APG4B/AUTL1 ，规格： 0.1ml

Ab-(001)-01112 N-甲基嘌呤DNA糖基化酶 ，英文名： Anti-APNG/MPG ，规格： 0.1ml

Ab-(001)-01113 载脂蛋白H抗体 ，英文名： Anti-ApoH ，规格： 0.1ml

Ab-(001)-01114 凝聚素α/β抗体 ，英文名： Anti-Apo J/Clusterin-α/β/Apolipoprotein J ，规格： 0.1ml

Ab-(001)-01115 Apollon凋亡抑制蛋白抗体 ，英文名： Anti-Apollon ，磷酸化蛋白激酶AKT1抗体规格： 0.1ml

Ab-(001)-01116 APP淀粉样肽前体蛋白抗体 ，英文名： Anti-APP/Amyloid beta A4 ，规格： 0.1ml

Ab-(001)-01117 磷酸化APP(Tyr757)淀粉样肽前体蛋白抗体 ，英文名： Anti-phospho-APP ，规格： 0.1ml